Results 111 to 120 of about 217,541 (259)

Inclusion Bodies in Hakuri

The Tohoku Journal of Experimental Medicine, 1959
Sakamoto, Akira, Suzuki, Sakae, Kondo, Kazuko, Furukaw, Toru   +3 more
openaire   +3 more sources

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

ADP‐ribosylation: An emerging regulator of the epigenome

Molecular Oncology, EarlyView.
ADP‐ribosylation has emerged as a dynamic epigenetic signaling mechanism that modifies histones and chromatin‐associated proteins. Through coordinated PARylation and MARylation, it integrates with other histone modifications to regulate chromatin structure, transcription factor activity, and gene expression, influencing genome function and disease ...
Cristel V. Camacho, Chenqian Liu, W. Lee Kraus   +2 more
wiley   +1 more source

Potential of inclusion bodies for disease control in aquaculture and livestock. [PDF]

Vet Anim Sci
López DV, Gallardo-Matus J, Torrealba D.   +2 more
europepmc   +1 more source

Ebola virus inclusion bodies are liquid organelles whose formation is facilitated by nucleoprotein oligomerization. [PDF]

Emerg Microbes Infect, 2023
Bodmer BS, Vallbracht M, Ushakov DS, Wendt L, Chlanda P, Hoenen T.   +5 more
europepmc   +1 more source

Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation

Molecular Oncology, EarlyView.
Partial inhibition of focal adhesion kinase (FAK) can paradoxically promote tumor growth, rather than simply producing a weaker antitumor effect than that observed with strong FAK suppression. In breast cancer and melanoma models, targeting p110δ PI3K, particularly in macrophages, counteracted these tumor‐promoting effects, highlighting the importance ...
Lydia Xenou, Niki Tzenaki, Anna Tsapara, Maria Tzardi, Evangelia A. Papakonstanti   +4 more
wiley   +1 more source

Refolding Protocol of the Cysteine-Rich Domain of Frizzled8 from Inclusion Bodies. [PDF]

Int J Mol Sci
Lee HJ, Zheng JJ.
europepmc   +1 more source

Arginine methylation as a regulatory ratchet in cancer: From substrate selection to malignant‐state stabilization

Molecular Oncology, EarlyView.
Arginine methylation can be viewed as a persistence‐prone post‐translational modification regulated by a network of PRMTs. Competitive and compensatory interactions among PRMTs can redistribute methylation across substrate pools shaped by sequence, structural, spatial, and environmental layers, reinforcing RNA‐processing, chromatin, and signaling ...
So Hyun Kwon, Ji Min Lee
wiley   +1 more source

The p40 fusion domain as a scaffold for producing functional inclusion bodies. [PDF]

Appl Microbiol Biotechnol
Vijayakumar S, Khetan R, Sunna A.
europepmc   +1 more source

Borderline phyllodes tumour of the breast with eosinophilic inclusion bodies: Case report and molecular sequencing. [PDF]

Int J Surg Case Rep, 2023
Lam NM, Noël JC, d'Haene N, Salmon I, Vandermeersch B, Catteau X.   +5 more
europepmc   +1 more source